Dr. Schallenkamp is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
801 N 29th St
Billings, MT 59101Phone+1 406-633-3305
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Residency, Radiation Oncology, 2001 - 2005
- Aurora Health CareInternship, Transitional Year, 2000 - 2001
- Medical College of WisconsinClass of 2000
Certifications & Licensure
- MT State Medical License 2005 - 2025
- WY State Medical License 2005 - 2025
- MN State Medical License 2001 - 2005
- WI State Medical License 2004 - 2005
- CO State Medical License 1996 - 1999
- American Board of Radiology Radiation Oncology
Clinical Trials
- Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors Start of enrollment: 2018 Oct 26
- Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations Start of enrollment: 2018 Aug 01
- Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer Start of enrollment: 2019 Jul 25
- Join now to see all
Publications & Presentations
PubMed
- Phase II randomized study of maintenance atezolizumab (A) versus atezolizumab + talazoparib (AT) in patients with SLFN11 positive extensive stage small cell lung cance...Nagla Abdel Karim, Jieling Miao, Karen L Reckamp, Carl M Gay, Lauren A Byers
Journal of Thoracic Oncology. 2024-11-04 - SWOG/NCI Phase II Dual Anti-CTLA-4/PD-1 Blockade in Rare Tumors (DART): Non-Epithelial Ovarian Cancer.Young Kwang Chae, Megan Othus, Sandip Pravin Patel, Kelly J Wilkinson, Emily M Whitman-Purves
Clinical Cancer Research. 2024-10-17 - First Report of NRG Oncology/Radiation Therapy Oncology Group 0622: A Phase 2 Trial of Samarium-153 Followed by Salvage Prostatic Fossa Irradiation in High-Risk Clinic...Richard K. Valicenti, Stephanie L. Pugh, Edouard J. Trabulsi, Oliver Sartor, Eric C. Ko
International Journal of Radiation Oncology, Biology, Physics. 2018-03-01
Press Mentions
- Billings Clinic Fires CEOMay 21st, 2019
- SWOG Reports Results in Gynecologic Cancer Immunotherapy TrialJanuary 20th, 1970
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: